Pseudoscience has recently re-emerged in the U.S. While much of it concerns vaccines, an "oldie" is again making the rounds: ...

has a long half-life allowing for once-daily dosing in treatment-naive patients and has less pharmacokinetic variability compared with other HIV INSTIs. For treatment-naive patients, dolutegravir ...

Although the risk is very low, this may influence your decision about switching to injectable treatment. Visit the A-Z of antiretroviral medications to find out more about these research studies.

THE spending this year of Security Bank Corp. would be slower than what the market witnessed last year as key executives said the lender seeks to squeeze profits from its 3-year investment ...

TAKING up the cudgels for cooperatives playing key role in promoting economic growth and livelihood generation, Senator Sherwin T. Gatchalian has filed a resolution seeking an inquiry into a ...

2024 — Researchers have shown unprecedented control of SIV replication and decay of viral reservoirs by combining a stringent model of infection with the interruption of antiretroviral therapy ...

The advent of new antiretroviral medicines means that the effects of HIV can now be curbed, but only one in twenty infected people have so far benefited. For those living in developing countries, the ...

Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic. Confronting the HIV Epidemic: There's an App ...

With further research, early identification may lead to earlier intervention. HealthDay News — Machine learning models may be able to identify women with severe subjective cognitive decline (SCD) ...